Keep Us Strong WikiLeaks logo

Currently released so far... 64621 / 251,287

Articles

Browse latest releases

Browse by creation date

Browse by origin

A B C D F G H I J K L M N O P Q R S T U V W Y Z

Browse by tag

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Browse by classification

Community resources

courage is contagious

Viewing cable 08PARIS2129, U.S./FDA ORPHAN PRODUCT DEVELOPMENT GRANT AWARD FOR ECTOPIC

If you are new to these pages, please read an introduction on the structure of a cable as well as how to discuss them with others. See also the FAQs

Understanding cables
Every cable message consists of three parts:
  • The top box shows each cables unique reference number, when and by whom it originally was sent, and what its initial classification was.
  • The middle box contains the header information that is associated with the cable. It includes information about the receiver(s) as well as a general subject.
  • The bottom box presents the body of the cable. The opening can contain a more specific subject, references to other cables (browse by origin to find them) or additional comment. This is followed by the main contents of the cable: a summary, a collection of specific topics and a comment section.
To understand the justification used for the classification of each cable, please use this WikiSource article as reference.

Discussing cables
If you find meaningful or important information in a cable, please link directly to its unique reference number. Linking to a specific paragraph in the body of a cable is also possible by copying the appropriate link (to be found at theparagraph symbol). Please mark messages for social networking services like Twitter with the hash tags #cablegate and a hash containing the reference ID e.g. #08PARIS2129.
Reference ID Created Released Classification Origin
08PARIS2129 2008-11-20 10:40 2011-08-24 00:00 UNCLASSIFIED Embassy Paris
VZCZCXYZ0013
PP RUEHWEB

DE RUEHFR #2129 3251040
ZNR UUUUU ZZH
P 201040Z NOV 08
FM AMEMBASSY PARIS
TO SECSTATE WASHDC PRIORITY 4891
UNCLAS PARIS 002129 
 
SIPDIS 
 
FDA/HHS FOR PASS TO ELAINE FOSTER (IVC/PA) 
 
E.O. 12958: N/A 
TAGS: KSCA TBIO OTRA TPHY FR
 
SUBJECT: U.S./FDA ORPHAN PRODUCT DEVELOPMENT GRANT AWARD FOR ECTOPIC 
CUSHINGS SYNDROME. 
 
REf: STATE 93064 
 
ΒΆ1. ESTH Office has review the proposed research and Embassy Paris 
find no objection to the proposed research grant entitled "Ectopic 
Cushings Syndrome". 
 
 
STAPLETON